US OTC Guide In Reader's Digest

16 October 1994

The US Nonprescription Drug Manufacturers Association has funded the publication of an eight-page pull-out supplement to be included in the November issue of Reader's Digest, entitled Know What You're Taking.

The supplement is, according to the NDMA, a home study course on the proper use of nonprescription, over-the-counter medicines, aimed at helping the public use OTc medicines safely and responsibly. The guide will focus on women and families, emphasizing the importance of reading the labels. Other topics dealt with include how to check the product for signs of tampering, safe storage of OTC medicines, how to avoid drug interactions, dosing instructions for children and the need for extra care when pregnant or nursing. The guide will also describe the prescription to OTC product switch process.

The supplement will also appear in a number of other magazines such as New Choices and American Health, and a Spanish-language version is being distributed with the Reader's Digest Hispanic edition, Selecciones. Overall, the NDMA estimates that the guide will be seen by 54 million Americans.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight